Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SID 3712502
i
Other names:
SID 3712502, IMTPPE
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
University of Pittsburgh
Drug class:
Androgen receptor inhibitor
Related drugs:
‹
enzalutamide (78)
darolutamide (14)
bicalutamide (13)
flutamide (4)
EPI-7170 (1)
ONCT-534 (1)
rezvilutamide (0)
MVI-118 (0)
PT150 (0)
enzalutamide tablet (0)
enzalutamide (78)
darolutamide (14)
bicalutamide (13)
flutamide (4)
EPI-7170 (1)
ONCT-534 (1)
rezvilutamide (0)
MVI-118 (0)
PT150 (0)
enzalutamide tablet (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
AR expression
Prostate Cancer
AR expression
Prostate Cancer
SID 3712502
Sensitive: D – Preclinical
SID 3712502
Sensitive
:
D
SID 3712502
Sensitive: D – Preclinical
SID 3712502
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.